Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
2.520
-0.050 (-1.95%)
At close: Sep 23, 2026, 4:00 PM EDT
2.410
-0.110 (-4.37%)
Pre-market: Sep 24, 2026, 7:08 AM EDT
Xenetic Biosciences Market Cap
Xenetic Biosciences has a market cap or net worth of $5.9 million as of September 23, 2026. Its market cap has increased by 23.02% in one year.
Market Cap
5.90M
Enterprise Value
-566.95K
1-Year Change
23.02%
Ranking
Category
Stock Price
$2.52
ChartMarket Cap Chart
Since June 30, 2016, Xenetic Biosciences's market cap has decreased from $47.70M to $5.90M, a decrease of -87.62%. That is a compound annual growth rate of -18.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 5.90M | 18.10% |
| Dec 31, 2025 | 5.00M | -19.35% |
| Dec 31, 2024 | 6.20M | 16.98% |
| Dec 29, 2023 | 5.30M | 23.26% |
| Dec 30, 2022 | 4.30M | -75.14% |
| Dec 31, 2021 | 17.30M | 35.16% |
| Dec 31, 2020 | 12.80M | 54.22% |
| Dec 31, 2019 | 8.30M | -46.10% |
| Dec 31, 2018 | 15.40M | -7.78% |
| Dec 29, 2017 | 16.70M | -53.09% |
| Dec 30, 2016 | 35.60M | -25.37% |
| Jun 30, 2016 | 47.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Skye Bioscience | 7.88M |
| XTL Biopharmaceuticals | 7.87M |
| Longeveron | 7.81M |
| Traws Pharma | 7.68M |
| CNS Pharmaceuticals | 7.63M |
| Acurx Pharmaceuticals | 7.01M |
| Enveric Biosciences | 6.98M |
| Bolt Biotherapeutics | 6.92M |